This study evaluates whether immediate lymphatic reconstruction (ILR) helps prevent lymphedema in breast cancer patients. Researchers hope to learn more about the development, progression, and prevention of lymphedema.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06650592.
Locations matching your search criteria
United States
Illinois
Chicago
University of Chicago Comprehensive Cancer CenterStatus: Active
Contact: Summer E. Hanson
Phone: 773-702-6302
PRIMARY OBJECTIVES:
I. Determine the efficacy of immediate lymphatic reconstruction (ILR) based on objective circumference, volume, and bioimpedance spectroscopy measurements of affected and unaffected limbs of women in the prophylactic lymphedema database.
II. Determine the impact of ILR on validated patient reported outcome tools including the lymphedema life impact scale and upper extremity range of motion and shoulder scores between affected and unaffected limbs.
III. Characterize the axillary microbiome in limbs that have been treated with ILR compared to those that were unaffected.
OUTLINE: This is an observational study.
Patients complete survey and undergo limb circumference measurements of each arm, range of motion assessments, bioimpedance spectroscopy, and axillary skin swab sample collection on study. Patients also have their medical records reviewed on study.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationUniversity of Chicago Comprehensive Cancer Center
Principal InvestigatorSummer E. Hanson
